Promising new data shows Pfizer's vaccine can overcome its ultra-cold storage requirements, as new research hints at just how effective the shot is
Pfizer announced Friday that they are seeking approval from the FDA to store its COVID-19 vaccine at higher temperatures.Pfizer is seeking approval from the FDA to store COVID-19 vaccines at higher temperatures.New research has also found the two-dose shot to be highly effective after one dose.Pfizer and BioNTech announced Friday that they are seeking approval from the US Food and Drug Administration.
Pfizer CEO Albert Bourla in a press release said,"We appreciate our ongoing collaboration with the FDA and CDC as we work to ensure our vaccine can be shipped and stored under increasingly flexible conditions. If approved, this new storage option would offer pharmacies and vaccination centers greater flexibility in how they manage their vaccine supply."
The data"does not show any change in the efficacy of the vaccine's ability to protect against COVID-19 disease" when stored at the higher temperatures, Pfizer spokesperson Jerica Pitts told Insider in a statement. Pfizer and BioNTech's vaccine was the first COVID-19 vaccine to be approved in the US but the vials have to be stored at